Pérez-Sánchez, C.; Barbarroja, N.; Pantaleão, L.C.; López-Sánchez, L.M.; Ozanne, S.E.; Jurado-Gámez, B.; Aranda, E.; Lopez-Pedrera, C.; RodrÃguez-Ariza, A.
Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer. J. Pers. Med. 2021, 11, 111.
https://doi.org/10.3390/jpm11020111
AMA Style
Pérez-Sánchez C, Barbarroja N, Pantaleão LC, López-Sánchez LM, Ozanne SE, Jurado-Gámez B, Aranda E, Lopez-Pedrera C, RodrÃguez-Ariza A.
Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer. Journal of Personalized Medicine. 2021; 11(2):111.
https://doi.org/10.3390/jpm11020111
Chicago/Turabian Style
Pérez-Sánchez, Carlos, Nuria Barbarroja, Lucas C. Pantaleão, Laura M. López-Sánchez, Susan E. Ozanne, Bernabé Jurado-Gámez, Enrique Aranda, Chary Lopez-Pedrera, and Antonio RodrÃguez-Ariza.
2021. "Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer" Journal of Personalized Medicine 11, no. 2: 111.
https://doi.org/10.3390/jpm11020111
APA Style
Pérez-Sánchez, C., Barbarroja, N., Pantaleão, L. C., López-Sánchez, L. M., Ozanne, S. E., Jurado-Gámez, B., Aranda, E., Lopez-Pedrera, C., & RodrÃguez-Ariza, A.
(2021). Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer. Journal of Personalized Medicine, 11(2), 111.
https://doi.org/10.3390/jpm11020111